Creative Biogene Expands Its Cutting-Edge CDMO Microbial Services

Creative Biogene Expands Its Cutting-Edge CDMO Microbial Services

Creative Biogene proudly announces its comprehensive suite of CDMO microbial services aimed at accelerating the production of essential commercial substances, aiming to delivering high-quality microbial production services Shirley, NY – November

Read More

Advanced Freezer-Safe Tape Demonstrates Exceptional Adhesion Retention at Minus Eighteen Degrees Celsius for Cold Chain Applications

Shaoxing, Zhejiang, China – November 03, 2026 Freezer safe is not one property but four, and the one buyers forget to test is the one that decides whether the box

Read More

Advanced CMP750 Electric Motor Concrete Mixer Enters Global Market

Qingdao, Shandong, China – November 03, 2026 – Electric Motor Concrete Mixer is equipped with special sealing device, which makes the sealing more reliable and environmental protection more powerful. The design

Read More

Exploring What Defines a HighPerformance Aluminum Decking Board Today

Guangzhou, Guangdong, China – November 03, 2026 – So, an Aluminum Decking Borad is basically a deck surface made from formed aluminum. It usually has a textured top and these channels

Read More

Bulimia Nervosa Market is Projected to Witness Significant Growth by 2036 Owing to Rising Disease Awareness and Increasing Demand for Effective Treatment Approaches | DelveInsight

The market dynamics for Bulimia Nervosa are expected to witness steady growth, driven by increasing awareness of eating disorders, rising diagnosis rates, expanding access to specialized mental healthcare, and growing

Read More

Acute Myocardial Infarction Market Size in the 7MM is projected to grow at a 13% CAGR over the forecast period of 2026-2036 | DelveInsight

The Key Acute Myocardial Infarction Companies in the market include – AGEPHA Pharma, Genentech, Amgen, Merck, Regeneron, Sanofi, Idorsia Pharmaceuticals, Viatris, Recardio, AstraZeneca, Faraday Pharmaceuticals, Novo Nordisk, and others. (Albany,

Read More

Ocular Hypertension Market is Expected to Witness Growth by 2034 Owing to the Rising Prevalence of Elevated Intraocular Pressure and Growing Focus on Glaucoma Prevention | DelveInsight

The ocular hypertension market is expected to witness growth driven by the increasing prevalence of elevated intraocular pressure (IOP), growing awareness of its association with primary open-angle glaucoma (POAG), and

Read More

Hypercholesterolemia Market Projected to Achieve Substantial Growth by 2036, Led by Key Companies and Strategic Developments | Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx

The Key Hypercholesterolemia Companies in the market include – Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx Therapeutics, Chroma Medicine, Verve Therapeutics, Inc, Vaxxinity, Inc, Arrowhead Pharmaceuticals, Merck Sharp &

Read More

Heart Failure Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Abbott, Berlin Heart GmbH, Biotronik, Boston Scientific Corp, Jarvik Heart Inc

(Albany, New York) – November 03, 2026: As per DelveInsight’s assessment, globally, Heart Failure pipeline constitutes 70+ key companies continuously working towards developing 75+ Heart Failure treatment therapies, analysis of

Read More

22q11.2 Deletion Syndrome Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight

The Key 22q11.2 Deletion Syndrome Companies in the market include – Sumitomo Pharma, Enzyvant, Roivant Sciences, Zynerba Pharmaceuticals, Harmony Biosciences, Nobias Therapeutics, and others. (Albany, US), November 3, 2026 –

Read More

Frontotemporal Dementia Market Size in the 7MM is projected to grow at a ~15% CAGR over the forecast period of 2026-2036 | DelveInsight

The Key Frontotemporal Dementia Companies in the market include – Passage Bio, Denali Therapeutics, Vesper Bio, AviadoBio, Transposon Therapeutics, Alector, and others. (Albany, US), November 03, 2026 – DelveInsight’s ‘Frontotemporal

Read More

Metastatic HR+/HER2− Breast Cancer Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight

The Key Metastatic HR+/HER2− Breast Cancer Companies in the market include – Novartis, Eli Lilly, AstraZeneca, Pfizer, Sermonix Pharmaceuticals, Veru Pharma, Arvinas, Olema Pharmaceuticals, Celcuity, and others. (Albany, US), November

Read More

Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen

(Albany, New York) – November 03, 2026: As per DelveInsight’s assessment, globally, Cutaneous Lupus Erythematosus pipeline constitutes 8+ key companies continuously working towards developing 10+ Cutaneous Lupus Erythematosus treatment therapies,

Read More

Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology

The Key Gastric Cancer Companies in the market include – AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharmaceuticals, BeiGene, and Zymeworks, ALX Oncology, Pfizer, KLUS Pharma, Enliven Therapeutics, Hubro Therapeutics,

Read More

What’s Fueling the Ovarian Cancer Market Boom? Industry to Cross USD 5.7 Billion by 2034 | pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio, Genmab, Tesaro

The Key Ovarian Cancer Companies in the market include – pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio/Genmab, Mario Negri Institute, Tesaro, Inc., Bristol-Myers Squibb, Merck Sharp & Dohme,

Read More

Mantle Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Mantle Cell Lymphoma Clinical Trial analysis report delivers important insights into ongoing research on 45+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November 03,

Read More

Glucagon-Like Peptide Agonist Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Glucagon-Like Peptide Agonist Clinical Trial analysis report delivers important insights into ongoing research on 45+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November 03,

Read More

Autism Spectrum Disorder Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Autism Spectrum Disorder Clinical Trial analysis report delivers important insights into ongoing research on 18+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November 03,

Read More

Post-Traumatic Stress Disorder Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Post-Traumatic Stress Disorder Clinical Trial analysis report delivers important insights into ongoing research on 20+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, New York, USA) On

Read More

Anterior Cruciate Ligament Injuries Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Anterior Cruciate Ligament Injuries market analysis report delivers important insights into ongoing research on pipeline Anterior Cruciate Ligament Injuries therapies, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)

Read More